Enables commercialisation for the first two entrants in the world’s second-largest semaglutide market.... May 05
OneSource Speciality Pharma Limited today announced that its partner Orbicular Pharmaceutical Technologies , together with its U.S.-based front-end partner, has secured tentative U.... Apr 23
Medical innovation has provided powerful tools to address one of the world’s most pressing health challenges. But the path to lasting wellness still requires ... Mar 07
The debate between pharmacotherapy and surgery will continue, but patients deserve nuanced guidance grounded in evidence, not trends... Feb 26
... Feb 11
From weight-loss injections to oat drinks, the internet’s obsession with quick fixes shows no sign of slowing down. The latest trend making waves ... Jan 31
As India confronts an alarming rise in obesity and related conditions like type 2 diabetes, cardiovascular disease, and polycystic ovarian syndrome, the spotlight on medical ... Jun 25
... May 12
A somewhat promising era of weight management has arrived. Ozempic and Mounjaro are no longer just for diabetes. But it’s not all magic. Risks, ... May 10
Ozempic has sparked a conversation that goes beyond pharmacology. It touches on the way we define wellbeing, the pressures we place on our bodies, and ... Apr 23
Ozempic is not officially available in India and is not approved for use in India. While the demand for Ozempic is high, the supply is ... Jan 23
The next time you reach for that bag of chips or can of soda, remember: what’s easy today may be costly tomorrow. Choose wisely.... Dec 06
In response to the market demand, Indian drugmakers, including Cipla, are actively developing generic versions of these weight-loss drugs to secure a larger market ... May 13
Celebrities vouch for them, but weight loss drugs like Wegovy, Ozempic, Saxenda, and Victoza pose serious digestive risks. Recent research reveals the downside, shedding light ... Oct 07
-Advertisements-